Seriously Ill Patients’ Willingness To Trade Survival Time To Avoid High Treatment Intensity At The End of Life
JAMA Network
Authors
Emily B. Rubin, MD, JD, MSHP: Anna Buehler, BA: Scott D. Halpern, MD, PhD
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
How Can a Behavioral Economics Lens Contribute to Implementation Science?
Implementation ScienceApril 26, 2024 -
Friends with Health Benefits: A Field Experiment
Management ScienceApril 17, 2024 -
Co-Designing Strategies To Implement Long-Acting Injectable PrEP for Sexual Minority Men in Chicago: A Study Protocol for an Innovation Tournament and Implementation Mapping
Implementation Science CommunicationsMarch 25, 2024 -
Adolescent Preferences for a Pediatric Primary Care-Based Sexually Transmitted Infection and HIV Prevention Intervention
Journal of Adolescent HealthMarch 24, 2024 -
Measuring Quality-Weighted Hospital-Free-Days in Acute Respiratory Failure: A Modified Delphi Study
Annals of the American Thoracic SocietyMarch 20, 2024 -
Field Testing the Transferability of Behavioural Science Knowledge on Promoting Vaccinations
Nature Human BehaviourMarch 14, 2024 -
The Next Decade of Healthcare
HealthcareFebruary 29, 2024 -
Health Care Resource Utilization and Costs Associated With Diagnosed Medication Overuse Headache and Potential Acute Medication Overuse in Individuals With Migraine
CephalalgiaFebruary 27, 2024 -
Achieving Goals of Care Decisions in Chronic Critical Illness: A Multi-institutional Qualitative Study
ChestFebruary 16, 2024 -
How Do Surrogates Make Treatment Decisions for Patients With Dementia: An Experimental Survey Study
Health EconomicsFebruary 15, 2024 -
Evaluating the Implementation of a Community Health Worker-Delivered Intervention Integrating Asthma Care in West Philadelphia Public Schools
Journal of AsthmaFebruary 9, 2024 -
Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting
Clinical Lymphoma Myeloma LeukemiaFebruary 8, 2024